$2.48T
Total marketcap
$57.89B
Total volume
BTC 50.62%     ETH 15.15%
Dominance

Cencora, Inc. 0HF3.L Stock

234.29 USD {{ price }} -0.852729% {{change_pct}}%
Exchange
LSE
Market Cap
487.11M USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
56 USD
{{ volume }}
P/E Ratio
0.28
Earnings per share
8.2 USD

Cencora, Inc. Price Chart

Cencora, Inc. 0HF3.L Financial and Trading Overview

Cencora, Inc. stock price 234.29 USD
Previous Close 178.85 USD
Open 0 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0 - 0 USD
52 Week Range 0 - 180.56 USD
Volume 2.28K USD
Avg. Volume 5.98K USD
Market Cap 375.41M USD
Beta (5Y Monthly) 0.522167
PE Ratio (TTM) 0.22025372
EPS (TTM) 8.2 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

0HF3.L Valuation Measures

Enterprise Value 41B USD
Trailing P/E 0.22025372
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.0015165629
Price/Book (mrq) 129.71552
Enterprise Value/Revenue 0.166
Enterprise Value/EBITDA 12.214

Trading Information

Cencora, Inc. Stock Price History

Beta (5Y Monthly) 0.522167
52-Week Change 28.58%
S&P500 52-Week Change 20.43%
52 Week High 180.56 USD
52 Week Low 0 USD
50-Day Moving Average 169.9 USD
200-Day Moving Average 158.48 USD

0HF3.L Share Statistics

Avg. Volume (3 month) 5.98K USD
Avg. Daily Volume (10-Days) 4.04K USD
Shares Outstanding 211.93M
Float 168.34M
Short Ratio N/A
% Held by Insiders 16.95%
% Held by Institutions 77.93%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.89
Trailing Annual Dividend Yield 1.05%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends September 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End September 30, 2023

Profitability

Profit Margin 0.65%
Operating Margin (ttm) 1.04%
Gross Margin 3.40%
EBITDA Margin 1.35%

Management Effectiveness

Return on Assets (ttm) 2.79%
Return on Equity (ttm) 221.03%

Income Statement

Revenue (ttm) 247.54B USD
Revenue Per Share (ttm) 1203.91 USD
Quarterly Revenue Growth (yoy) 9.90%
Gross Profit (ttm) 8.33B USD
EBITDA 3.36B USD
Net Income Avi to Common (ttm) 1.62B USD
Diluted EPS (ttm) 8.198
Quarterly Earnings Growth (yoy) -20.50%

Balance Sheet

Total Cash (mrq) 1.54B USD
Total Cash Per Share (mrq) 7.6 USD
Total Debt (mrq) 6.26B USD
Total Debt/Equity (mrq) 1225.56 USD
Current Ratio (mrq) 0.887
Book Value Per Share (mrq) 1.392

Cash Flow Statement

Operating Cash Flow (ttm) 2.91B USD
Levered Free Cash Flow (ttm) 3.69B USD

Profile of Cencora, Inc.

Country United Kingdom
State PA
City Conshohocken
Address 1 West First Avenue
ZIP 19428-1800
Phone 610 727 7000
Website https://www.amerisourcebergen.com
Industry
Sector(s)
Full Time Employees 39000

AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Q&A For Cencora, Inc. Stock

What is a current 0HF3.L stock price?

Cencora, Inc. 0HF3.L stock price today per share is 234.29 USD.

How to purchase Cencora, Inc. stock?

You can buy 0HF3.L shares on the LSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Cencora, Inc.?

The stock symbol or ticker of Cencora, Inc. is 0HF3.L.

How many shares does Cencora, Inc. have in circulation?

The max supply of Cencora, Inc. shares is 2.08M.

What is Cencora, Inc. Price to Earnings Ratio (PE Ratio)?

Cencora, Inc. PE Ratio is 0.28578310 now.

What was Cencora, Inc. earnings per share over the trailing 12 months (TTM)?

Cencora, Inc. EPS is 8.2 USD over the trailing 12 months.